We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVRA icon
13001
Savara
SVRA
$1.11B
$72K ﹤0.01%
42,516
-105,663
-71% -$190K
FRBK
13002
CALL
DELISTED
Republic First Bancorp Inc
FRBK
$72K ﹤0.01%
18,000
+4,600
+34% +$18.5K
BIOC
13003
CALL
DELISTED
Biocept, Inc.
BIOC
$72K ﹤0.01%
573
-1,504
-72% -$204K
REED
13004
DELISTED
Reeds, Inc. Common Stock
REED
$72K ﹤0.01%
+1,406
New +$72.3K
NH
13005
PUT
DELISTED
NantHealth, Inc
NH
$72K ﹤0.01%
2,073
-914
-31% -$36.3K
AIRI icon
13006
Air Industries Group
AIRI
$12.3M
$71K ﹤0.01%
5,493
+825
+18% +$10.4K
AVTX icon
13007
PUT
Avalo Therapeutics
AVTX
$1.05B
$71K ﹤0.01%
8
+4
+100% +$33.5K
BMRA icon
13008
Biomerica
BMRA
$4.88M
$71K ﹤0.01%
+2,222
New +$75.3K
EVOK
13009
CALL
DELISTED
Evoke Pharma
EVOK
$71K ﹤0.01%
358
+41
+13% +$8.78K
LGHL
13010
CALL
Lion Group Holding
LGHL
$729K
0
MOVE icon
13011
Corvex Inc
MOVE
$324M
$71K ﹤0.01%
+126
New +$73.4K
RKDA icon
13012
PUT
Arcadia Biosciences
RKDA
$1.36M
$71K ﹤0.01%
601
-110
-15% -$12K
SIFY
13013
CALL
Sify Technologies
SIFY
$1.13B
$71K ﹤0.01%
3,267
-4,466
-58% -$87.8K
TEF
13014
CALL
DELISTED
Telefonica
TEF
$71K ﹤0.01%
16,187
-16,679
-51% -$72.2K
ATYR
13015
CALL
aTyr Pharma
ATYR
$54.8M
$71K ﹤0.01%
+14,500
New +$61.8K
SLHG
13016
DELISTED
Skylight Health Group Inc Common Shares
SLHG
$71K ﹤0.01%
+17,354
New +$78.1K
TLMD
13017
CALL
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$71K ﹤0.01%
12,500
+600
+5% +$3.99K
TALKW
13018
DELISTED
Talkspace Inc Warrant
TALKW
$70K ﹤0.01%
51,244
+1,215
+2% +$1.62K
VOC icon
13019
CALL
VOC Energy
VOC
$53.9M
$70K ﹤0.01%
14,700
-900
-6% -$3.53K
AENZ
13020
DELISTED
Aenza S.A.A.
AENZ
$70K ﹤0.01%
+13,721
New +$71K
KBNT
13021
CALL
DELISTED
Kubient, Inc. Common Stock
KBNT
$70K ﹤0.01%
+12,300
New +$71.6K
SREV
13022
CALL
DELISTED
ServiceSource International, Inc.
SREV
$70K ﹤0.01%
49,400
+500
+1% +$658
LJPC
13023
PUT
DELISTED
La Jolla Pharmaceutical Company
LJPC
$70K ﹤0.01%
16,300
+3,500
+27% +$15K
FAX
13024
abrdn Asia-Pacific Income Fund
FAX
$599M
$69K ﹤0.01%
+2,603
New +$67.1K
HEPA
13025
PUT
DELISTED
Hepion Pharmaceuticals
HEPA
$69K ﹤0.01%
35
+12
+52% +$22K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.